A thymidine kinase deficient HSV‐2 strain causes acute keratitis and establishes trigeminal ganglionic latency, but poorly reactivates in vivo

The incidence of herpetic keratitis following in‐tranasal or direct ocular infection with thymidine kinase‐negative (TK−) strains of herpes simplex virus (HSV)‐2 has not been well studied, and the role of the TK gene in the establishment of latency and virus reactivation is controversial. To determine whether a TK− strain of HSV‐2 could establish trigeminal ganglionic latency and be reactivated in vivo to produce recurrent keratitis or nervous system infection, an animal model of acute and recurrent infection was utilized. Rabbits were infected by the intranasal or ocular routes, and latency was reactivated by immuno‐suppression. Virus shedding in nasal and ocular secretions was monitored, and the eyes were examined for the presence of corneal epithelial lesions during acute and reactivated infections. Central nervous system (CNS) and trigeminal ganglionic tissues were assayed by histologic, virologic, and in situ hybridization techniques. All rabbits intranasally infected shed virus in both ocular and nasal secretions, whereas only 30% of rabbits infected in the eyes shed virus in nasal secretions. Virus was recovered from co‐cultivation cultures, but not from cell‐free ho‐mogenates, of trigeminal ganglionic and CNS tissues from animals inoculated by both routes. The incidence of keratitis was much greater after direct ocular inoculation, although both routes of inoculation produced CNS and ganglionic inflammatory lesions. Keratitis healed in 92% of the animals infected by the ocular route by 26 days post infection. Of rabbits initially infected in the eyes and then subjected to drug‐induced reactivation, only 30% shed virus, which was limited to a 24 hour period; there was no reappearance of epithelial keratitis, no animal became blind, and none died. In contrast, latently infected control rabbits uniformly reactivated. These studies show that this TK− HSV‐2 strain (i) replicates in the eye, (ii) is neuroinvasive but non‐neurovirulent following intranasal and direct ocular infection; (iii) sheds in the eye more frequently and for longer periods after ocular than after intranasal inoculation; (iv) induces epithelial keratitis that usually heals spontaneously; (v) establishes latency in trigeminal ganglionic neurons, but no other ganglionic cells; and, (vi) reactivates in a small proportion of animals, but does not produce recurrent ocular lesions following drug‐induced immunosuppres‐sion. Thus, the TK gene appears directly involved in HSV latency and reactivation in vivo. © 1994 Wiley‐Liss, Inc.

[1]  W. G. Stroop,et al.  The Weakly Virulent Herpes Simplex Virus Type 1 Strain KOS-63 Establishes Peripheral and Central Nervous System Latency Following Intranasal Infection of Rabbits, but Poorly Reactivates In Vivo , 1992, Journal of neuropathology and experimental neurology.

[2]  E. Cantin,et al.  Persistence of herpes simplex virus DNA in rabbit corneal cells. , 1992, Investigative ophthalmology & visual science.

[3]  T. Margolis,et al.  Pathways of viral gene expression during acute neuronal infection with HSV-1. , 1992, Virology.

[4]  J. Paolini,et al.  Characterization of a novel human corneal endothelial antigen. , 1991, Investigative ophthalmology & visual science.

[5]  M. Forsgren,et al.  Intrathecal antibody production against viruses of the herpesvirus family in acute retinal necrosis syndrome. , 1991, American journal of ophthalmology.

[6]  B. D. de Galan,et al.  Expression of herpes simplex virus type 2 latency-associated transcript in neurons and nonneurons , 1991, Journal of virology.

[7]  J. Cherry,et al.  Detection of herpes simplex virus thymidine kinase and latency-associated transcript gene sequences in human herpetic corneas by polymerase chain reaction amplification. , 1991, Investigative ophthalmology & visual science.

[8]  E. De Clercq,et al.  (S)-1-(3-hydroxy-2-phosphonyl-methoxypropyl)cytosine in the therapy of thymidine kinase-positive and -deficient herpes simplex virus experimental keratitis. , 1991, Investigative ophthalmology & visual science.

[9]  S. Kaye,et al.  Evidence for herpes simplex viral latency in the human cornea. , 1991, The British journal of ophthalmology.

[10]  M. Yamada,et al.  Reactivatable latency of three avirulent strains of herpes simplex virus type 1 after intranasal inoculation in mice. , 1991, Acta medica Okayama.

[11]  E. Cantin,et al.  Detection of herpes simplex virus DNA sequences in corneal transplant recipients by polymerase chain reaction assays. , 1991, Current eye research.

[12]  W. Baehr,et al.  HSV antigens and HSV DNA in avascular and vascularized lesions of human herpes simplex keratitis. , 1991, Current eye research.

[13]  R. Tenser Role of herpes simplex virus thymidine kinase expression in viral pathogenesis and latency. , 1991, Intervirology.

[14]  B. Roizman,et al.  Mapping of herpes simplex virus-1 neurovirulence to gamma 134.5, a gene nonessential for growth in culture. , 1990, Science.

[15]  D. McGeoch,et al.  Characterization of herpes simplex virus type 2 transcription during latent infection of mouse trigeminal ganglia , 1990, Journal of virology.

[16]  Brown Sm,et al.  Multigenic control of virus virulence in intertypic recombinants of herpes simplex virus. , 1990 .

[17]  D. Coen,et al.  Quantitative polymerase chain reaction analysis of herpes simplex virus DNA in ganglia of mice infected with replication-incompetent mutants , 1990, Journal of virology.

[18]  J. Ganley,et al.  Cytopathogenicity, drug susceptibility, and thymidine kinase activity of a retinovirulent herpes simplex virus type 2 , 1990, Journal of medical virology.

[19]  Brown Sm,et al.  Herpes simplex virus genes controlling reactivation from latency in rabbit eye model. , 1990 .

[20]  G. Naumann,et al.  Herpes simplex stromal and endothelial keratitis. Granulomatous cell reactions at the level of Descemet's membrane, the stroma, and Bowman's layer. , 1990, Ophthalmology.

[21]  W. G. Stroop,et al.  Spread of herpes simplex virus type 1 in the central nervous system during experimentally reactivated encephalitis. , 1990, Microbial pathogenesis.

[22]  M. Forsgren,et al.  Late ophthalmologic manifestations of neonatal herpes simplex virus infection. , 1990, American journal of ophthalmology.

[23]  R. Sandri-Goldin,et al.  Latent infections in spinal ganglia with thymidine kinase-deficient herpes simplex virus , 1989, Journal of virology.

[24]  S. Brown,et al.  A herpes simplex virus type 2 variant in which a deletion across the L-S junction is replaced by single or multiple reiterations of extraneous DNA. , 1989, The Journal of general virology.

[25]  J. Ganley,et al.  Isolation of a herpes simplex virus type 2 that is retinovirulent in mice. , 1989, Current eye research.

[26]  R. Tenser,et al.  Latency-associated transcript but not reactivatable virus is present in sensory ganglion neurons after inoculation of thymidine kinase-negative mutants of herpes simplex virus type 1 , 1989, Journal of virology.

[27]  K. Tyler,et al.  Thymidine kinase-negative herpes simplex virus mutants establish latency in mouse trigeminal ganglia but do not reactivate. , 1989, Proceedings of the National Academy of Sciences of the United States of America.

[28]  A. Minson,et al.  The role of herpes simplex virus type 1 thymidine kinase in pathogenesis. , 1989, The Journal of general virology.

[29]  W. G. Stroop,et al.  Neurovirulence of Two Clonally Related Herpes Simplex Virus Type 1 Strains in a Rabbit Seizure Model , 1989, Journal of neuropathology and experimental neurology.

[30]  H. Kaufman,et al.  Corneal nerves are necessary for adrenergic reactivation of ocular herpes. , 1988, Investigative ophthalmology & visual science.

[31]  R. Longnecker,et al.  Virulence of and establishment of latency by genetically engineered deletion mutants of herpes simplex virus 1. , 1988, Virology.

[32]  R. Tenser,et al.  Trigeminal ganglion infection by thymidine kinase-negative mutants of herpes simplex virus after in vivo complementation , 1987, Journal of virology.

[33]  E. Wagner,et al.  RNA complementary to a herpesvirus alpha gene mRNA is prominent in latently infected neurons. , 1987, Science.

[34]  W. G. Stroop,et al.  Severity of experimentally reactivated herpetic eye disease is related to the neurovirulence of the latent virus. , 1987, Investigative ophthalmology & visual science.

[35]  M. Rayfield,et al.  Strain specificity of spontaneous and adrenergically induced HSV-1 ocular reactivation in latently infected rabbits. , 1987, Current eye research.

[36]  J. Oakes,et al.  Failure of intertypic recombinant constructed from HSV-1 x HSV-2 virulent parents to induce ocular pathology. , 1987, Current eye research.

[37]  R. Dix,et al.  Histopathologic characteristics of two forms of experimental herpes simplex virus retinitis. , 1987, Current eye research.

[38]  J. Reynolds,et al.  Congenital herpes simplex retinitis. , 1986, American journal of ophthalmology.

[39]  W. G. Stroop,et al.  Production of encephalitis restricted to the temporal lobes by experimental reactivation of herpes simplex virus. , 1986, The Journal of infectious diseases.

[40]  J. Martin,et al.  Central nervous system and genital infection with reactivation of latent herpes simplex virus type 2 in mice. , 1986, Microbial pathogenesis.

[41]  W. G. Stroop Herpes simplex virus encephalitis of the human adult: reactivation of latent brain infection. , 1986, Pathology and immunopathology research.

[42]  D. Rock,et al.  Localization of herpes simplex virus in the trigeminal and olfactory systems of the mouse central nervous system during acute and latent infections by in situ hybridization. , 1984, Laboratory investigation; a journal of technical methods and pathology.

[43]  R. L. Thompson,et al.  Biological characterization of a herpes simplex virus intertypic recombinant which is completely and specifically non-neurovirulent. , 1983, Virology.

[44]  J. Gerdes,et al.  Recurrence phenotypes and establishment of latency following rabbit keratitis produced by multiple herpes simplex virus strains. , 1983, The Journal of general virology.

[45]  Y. Becker,et al.  HSV-1 thymidine kinase promotes virulence and latency in the mouse. , 1983, Investigative ophthalmology & visual science.

[46]  I. Smith,et al.  Genital infection with herpes simplex virus type I. , 1982, The Journal of infection.

[47]  F. Rapp,et al.  Trigeminal ganglion infection by thymidine kinase-negative mutants of herpes simplex virus. , 1979, Science.

[48]  S. Kimura,et al.  Acute ocular infection by type 2 herpes simplex virus in adults. , 1975, Archives of ophthalmology.

[49]  D. R. Dubbs,et al.  Distinctive properties of thymidine kinase isozymes induced by human and avian herpesviruses , 1974, International journal of cancer.

[50]  D. R. Dubbs,et al.  Subcellular localization and properties of thymidine kinase from adenovirus-infected cells. , 1974, The Journal of general virology.